Biotech · Private company
Institut de Recherches Internationales Servier (I.R.I.S.)
Track this companyFree. Adds Institut de Recherches Internationales Servier (I.R.I.S.) to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- VorasidenibPhase 2 · Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 MutationClinicalTrials.gov · fetched Nov 12, 2026
- Vorasidenib 20mgPhase 1 · Severe Hepatic ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 MutationPHASE2 · RECRUITING · started Jul 23, 2026ClinicalTrials.gov NCT07286292 · fetched Nov 12, 2026
- Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control ParticipantsPHASE1 · RECRUITING · started Apr 23, 2026ClinicalTrials.gov NCT07250633 · fetched Nov 12, 2026